CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹13,454 Cr | ₹12,689 Cr | ₹11,732 Cr | ₹11,925 Cr | ₹11,628 Cr |
What is the latest Total Non-Current Assets ratio of CIPLA ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹13,454 Cr |
| Mar2024 | ₹12,689 Cr |
| Mar2023 | ₹11,732 Cr |
| Mar2022 | ₹11,925 Cr |
| Mar2021 | ₹11,628 Cr |
How is Total Non-Current Assets of CIPLA Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹13,454 Cr | 6.03 | |
| Mar2024 | ₹12,689 Cr | 8.16 | |
| Mar2023 | ₹11,732 Cr | -1.62 | |
| Mar2022 | ₹11,925 Cr | 2.55 | |
| Mar2021 | ₹11,628 Cr | - | |
Compare Total Non-Current Assets of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹99,593.7 Cr | 1.5% | -5.4% | -15.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹399,549.0 Cr | 1% | -6.4% | -0.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,862.0 Cr | 3.5% | 3.4% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,912.0 Cr | 0.2% | -1.8% | 33.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,891.0 Cr | -0.2% | -3.4% | 11.4% | Stock Analytics | |
| MANKIND PHARMA | ₹90,642.6 Cr | 3.1% | 2.5% | -9.7% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.5% |
-5.4% |
-15.4% |
| SENSEX | 3.2% |
5% |
5.5% |
You may also like the below Video Courses